SUNY Empire Innovation Program - Regenerative Medicine

Position: SUNY Empire Innovation Program - Regenerative Medicine - Binghamton University
Job Description:

The Thomas J. Watson College of Engineering and Applied Science at Binghamton University, and Upstate Medical University invite applications for two tenured faculty positions (one primary appointment at each campus) with an expected start date of Fall 2025 in the area of regenerative medicine. We are seeking national leaders in stem cell science, cell therapy, and biomanufacturing with special focus in pancreatic islet development, biomanufacturing, islet biology, islet transplantation, to be part of a collaborative research and education alliance between Binghamton University and Upstate Medical University.

This position will carry the title of SUNY Empire Innovation Professor, and is supported in part by the State University of New York (SUNY)'s Empire Innovation Program (EIP), a key initiative to recruit and retain outstanding faculty with an established track record of research and scholarship in areas of strategic priority.

We are seeking exceptional and well-established experts with outstanding track records of funded research, scholarship, teaching and service. Applications are invited from candidates in all areas of regenerative medicine, biomaterials, and tissue bio-fabrication. However, human pancreatic islet development, islet biomanufacturing, islet biology and islet transplantation are areas of particular interest.

Successful candidates will augment existing capabilities and expertise in regenerative medicine at Binghamton University and Upstate Medical University, build on ongoing research at both campuses and further strengthen and grow cross-institutional collaborations. They will be expected to make significant contributions to Binghamton university's Road Map Initiative in the Transdisciplinary Area of Excellence in Health Science (https://(Use the "Apply for this Job" box below).) and Upstate Medical University's Research Strategic Plan (https://).

They will develop and implement a robust plan to synergize and accelerate research partnerships between the Center of Biomanufacturing for Regenerative Medicine (CBRM) led by Watson College's Biomedical Engineering Department, Binghamton University's School of Pharmacy and Pharmaceutical Sciences, and the Basic Science and Clinical Departments at Upstate Medical University.

A premier public R1 research institution, Binghamton University contributes over $1.2 billion annually to the regional economy. The recent $113 million research award from Economic Development Agency (EDA) for battery technology innovation speaks to the university's leadership on knowledge transfer and partnerships across industrial and academia to advance technology development and innovation in science and engineering. The university attracts outstanding students and is home to award-winning faculty, many of whom are ranked in the top 2% of researchers in their respective fields, including the 2019 Nobel Laureate Dr.

Stanley Whittingham in the field of Chemistry.

The Biomedical Engineering Department is particularly strong in advanced biomanufacturing, stem cells, tissue engineering/regenerative medicine, nanomedicine, cardiovascular engineering, biomaterials, organ-on-a-chip, wearable biosensors, and biomechanics. It is home to the Center of Biomanufacturing for Regenerative Medicine. The Department runs a National Institute of Standards and Technology (NIST) PREP postdoc and graduate training program. For more information, please visit our website at: https://.

Upstate Medical University is the region's only Academic Medical Center located in Syracuse New York with two hospitals, a large clinical enterprise with a clinical campus in Binghamton and is comprised of four colleges:
The College of Medicine, The College of Graduate Studies, The College of Nursing, and The College of Health Professions. The largest employer in Central New York, Upstate contributes $2.5B annually to the regional economy. Upstate has a vibrant, impactful and growing research enterprise that has increased research expenditures 35% over the last four years culminating in total expenditures of $48M.

Basic and translational research is focused in five basic science departments, translational and clinical research in twenty clinical departments, and within research centers and institutes including: the Joslin Center for Diabetes, Clinical Research Unit, Institute for Global Health and Translational Science, the Center for Vision Research, the Sepsis Interdisciplinary Research Center, the Upstate Cancer Center, and the Neuroscience Research Institute.

Upstate maintains a large and growing clinical trials portfolio with an average of 600 open clinical trials. Upstate has a vibrant innovation and entrepreneurship ecosystem supported by an incubator, The Central New York Biotech Accelerator, one of the most successful incubators in New York State with an…